Public communication and knowledge dissemination are often thought of as straight cut, on/off types of action, especially in medicine and the broader health sciences. However it is also very evident in our present day that miscommunication and inaccurate knowledge sharing exists, and has increasingly harmful consequences on the global population. Examples of this are plenty, … Read more
This year’s #AHA19 meeting, despite its abbreviated 3-day format, delivered a fantastic lineup of basic science research sessions, comprising of presentations from trainees to early career and senior investigators. Here I review some of the major topics in basic science cardiovascular research highlighted at #AHA19! This is by no means a comprehensive list of all … Read more
The DAPA-HF trial was definitely the highlight of the scientific sessions at the AHA19 conference. I’m fascinated by the interesting outcomes and keen to learn more about the effect of SGLT-2 inhibitors on heart failure (HF) patients with preserved ejection fraction (HFpEF). In the next few lines, I’m going to briefly discuss the significant findings … Read more
This year’s scientific sessions of the American Heart Association (AHA) have been disruptive to common dogma. The Presidential Address was preceded by select songs from the Broadway musical, Hamilton. Not surprising, one of the song’s lyrics, “I want to be in the room where it happens,” caught my attention. We all want to be where … Read more
Research continues to mount showing that stress affects our health and well-being. The various daily experiences we face that lead to stress set off a cascade of physiological responses that, when experienced over a lifetime, can lead to diabetes, hypertension, and eventually heart attack and stroke. The effects of stress experienced over a lifetime are … Read more
Approximately 30-40% of AHA Scientific session attendees are from outside of the United States. Taking a couple (or more!) of flights, landing in a new city after a 23-hour trip from across the Atlantic and functioning at optimum levels during a meeting of such magnitude may well be a formidable task, particularly when it’s a … Read more
The ISCHEMIA trial definitely caused quite a chatter, and congratulations to the authors on a thought provoking and interesting study. I’m fascinated and can’t wait to do a deep dive on my own time. BUT, that’s for stable ischemic heart disease. There’s a time and a place for that, but that place is certainly not … Read more
#AHA19 was an amazing meeting in all aspects!! I totally enjoyed every moment and definitely recommend all fellows and early career cardiologists to attend and participate in this important meeting. I will share my experience and highlight important sessions fellows and early career colleagues should not miss. The fellow-in-training (FIT) and Early Career Lounge The … Read more
I’ve always been invested in lived narratives of others. Whether through a PhotoVoice project of patients with hypertension in Baltimore or people I meet in passing, I’ve never taken the presentation of a person or their behaviors at face value. As in my chosen field of inquiry—studying mechanisms underlying racial/ethnic disparities—each person I encounter presents … Read more
We are doing a pretty poor job of getting our patients with heart failure with reduced ejection fraction (HFrEF) on the appropriate guideline-directed medical therapies (GDMT). It is the talk of the town (and by town, I mean Twitter- and if you are not following Gregg Fonarow, MD @gcfmd on there, you need to because … Read more